Fate Therapeutics Profit Margin

The latest profit margin for FATE is -20.57% as of March 2026. That compares with -13.19% in the prior-year period — down 55.9% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Fate Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, FATE's profit margin moved from -13.19% to -20.57% — a 55.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fate Therapeutics's valuation or profitability profile.

Against Healthcare companies, FATE currently prints -20.57% for profit margin, while the sector average sits near 15.58%. That is roughly 13298.1% below the sector mean. Large gaps often invite a closer look at Fate Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Fate Therapeutics converts resources into returns. At -20.57%, FATE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -13.19% in the prior-year period — down 55.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting FATE's profit margin (-20.57%), review year-over-year change from -13.19%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.